|
DIAPH1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.11575201802816E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.11153317053459E-12 |
| Normal-vs-Stage2 |
1.059680E-03 |
| Normal-vs-Stage3 |
1.51349999999439E-06 |
| Normal-vs-Stage4 |
8.46970000000224E-05 |
| Stage1-vs-Stage2 |
4.839400E-01 |
| Stage1-vs-Stage3 |
4.023400E-01 |
| Stage1-vs-Stage4 |
4.302600E-01 |
| Stage2-vs-Stage3 |
9.469200E-01 |
| Stage2-vs-Stage4 |
9.851800E-01 |
| Stage3-vs-Stage4 |
9.580400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.15938378289593E-13 |
| Normal-vs-AfricanAmerican |
2.111600E-02 |
| Normal-vs-Asian |
1.625180E-01 |
| Caucasian-vs-AfricanAmerican |
1.147420E-01 |
| Caucasian-vs-Asian |
9.384600E-01 |
| AfricanAmerican-vs-Asian |
6.207800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.84750034452009E-10 |
| Normal-vs-Female |
7.08078040645432E-12 |
| Male-vs-Female |
5.486200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.010160E-01 |
| Normal-vs-Age(41-60Yrs) |
3.28326255072398E-12 |
| Normal-vs-Age(61-80Yrs) |
5.43639999683876E-09 |
| Normal-vs-Age(81-100Yrs) |
1.811600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.962200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.974400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.716370E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.874400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.191400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.323000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.596100E-02 |
| Normal-vs-Grade 2 |
3.48054918219987E-13 |
| Normal-vs-Grade 3 |
5.73999958675131E-10 |
| Normal-vs-Grade 4 |
3.167500E-02 |
| Grade 1-vs-Grade 2 |
6.675400E-01 |
| Grade 1-vs-Grade 3 |
5.447200E-01 |
| Grade 1-vs-Grade 4 |
9.766100E-02 |
| Grade 2-vs-Grade 3 |
5.144400E-01 |
| Grade 2-vs-Grade 4 |
2.997900E-03 |
| Grade 3-vs-Grade 4 |
2.232500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
3.377700E-03 |
| ccA subtype-vs-ccB subtype |
1.13129949852464E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.05350239222003E-11 |
| Normal-vs-N1 |
4.981900E-02 |
| N0-vs-N1 |
8.733000E-01 |
|
|
